Approval clinical trial showing that treatment with Lonsurf plus bevacizumab resulted in statistically significant and clinically meaningful improvements in overall survival in patients with previously […]
FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy TOKYO, Aug. 5, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President […]
June 28, 2023 — Today, the U.S. Food and Drug Administration approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor […]
FDA Approves Opvee (nalmefene hydrochloride) Prescription Nasal Spray to Reverse Opioid Overdose May 22, 2023 — Today, the U.S. Food and Drug Administration approved Opvee, […]
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 — Otsuka […]
FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) LEIDEN, The Netherlands, March 24, 2023 /PRNewswire/ — Pharming Group N.V. […]
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis SAN DIEGO & PARSIPPANY, N.J.–(BUSINESS WIRE)– March 22, 2023 — Cidara […]
La administración Biden se enfrenta a la creciente presión de los estados para que les permita importar medicamentos de Canadá con el fin de reducir […]